Key result
Women with operable breast cancer and >10 positive nodes had a 5-year overall survival of 63%, with better survival in those with 10-20 nodes compared to >20 nodes.
Why the study?
What are the survival outcomes in women with operable breast cancer and >10 positive axillary nodes treated with mastectomy and axillary dissection?
Cohort (n=259)
What are the survival outcomes in women with operable breast cancer and >10 positive axillary nodes treated with mastectomy and axillary dissection?
Women with operable breast cancer and >10 positive nodes have a 5-year survival of 63% following mastectomy and axillary dissection, with worse outcomes in those with >20 positive nodes.
Answers are grounded in this paper and cite their sources.
Guarded prognosis persists in breast cancer with extensive nodal involvement; leaves open impact of contemporary systemic therapies.
Two-hundred and fifty-nine women with operable breast cancer, having more than 10 involved nodes without a distant metastasis, were treated with radical, modified radical or partial mastectomy with complete axillary dissection. Survival at 5 years was 63% and at 7 years 54%. Fifty-six per cent and 52% were disease free 5 and 7 years after initial therapy. Postmenopausal women had an overall survival rate of 64% and disease free survival rate of 61% while premenopausal women had an overall survival of 58% and disease free survival of 52%. Survival and disease free survival rate for those with 10-20 positive nodes were 65% and 69% respectively, while for those with more than 20 positive nodes the rates were 49% and 52% respectively; a statistically better survival in the 2nd group. Although the observational time of patients having adjuvant CEF is short, a better survival rate and disease free survival rate is possible in women treated with CEF.
No takes yet. Share an insight, caveat, or question.
Keramopoullos et al. (2000) conducted a cohort in Operable breast cancer (n=259). Mastectomy with complete axillary dissection was evaluated on Survival at 5 years. Women with operable breast cancer and >10 positive nodes had a 5-year overall survival of 63%, with better survival in those with 10-20 nodes compared to >20 nodes.
Synapse has enriched 10 related papers. Consider them for comparative context: